Preclinical Drug Development
- UE code MSBMM102
-
Schedule
24 30Quarter 1
- ECTS Credits 6
-
Language
Français
- Teacher Gillet Jean-Pierre
Students will be able:
This course provides a comprehensive overview of preclinical drug development process. Each stage of the process is developed in-depth and presented according to the current EMA (European Medicines Agency) legislation.
Practicals
Oral exam: /16
Practicals: /4 including (1) Entry test before each session, and (2) reports submitted by group of two, one week after the practical.
The exact modalities of the evaluation are likely to be modified during the preparation of the examination schedules, depending on the practical constraints with which the faculty administration may be confronted, or in the event of illness / force majeure / encroachment with an internship, or because of the health situation related to the coronavirus.
PowerPoint presentations, textbook of practicals, research and review articles.
Training | Study programme | Block | Credits | Mandatory |
---|---|---|---|---|
Master 120 en sciences biomédicales à finalité spécialisée en recherche clinique | Standard | 0 | 6 | |
Master 60 en sciences biomédicales | Standard | 0 | 6 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche préclinique | Standard | 0 | 6 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche clinique | Standard | 1 | 6 | |
Master 60 en sciences biomédicales | Standard | 1 | 6 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche préclinique | Standard | 1 | 6 |